Related Experiment Videos
Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic
C G Frostell1, H Blomqvist, G Hedenstierna
1Department of Anaesthesia and Intensive Care, Danderyd Hospital, Sweden.
Anesthesiology
|March 1, 1993
Summary
Inhaling nitric oxide (NO) reversed low-oxygen-induced lung vessel constriction in healthy adults. This pulmonary vasodilation occurred without affecting systemic blood pressure or circulation.
Area of Science:
- Cardiovascular Physiology
- Respiratory Medicine
- Pulmonary Circulation
Background:
- Nitric oxide (NO) functions as a local vasodilator produced by the endothelium.
- Understanding NO's role in pulmonary and systemic circulation is crucial.
Purpose of the Study:
- To investigate the effects of inhaled nitric oxide (NO) on pulmonary and systemic circulation in healthy human volunteers.
- To determine if NO can reverse hypoxic pulmonary vasoconstriction.
Main Methods:
- Nine healthy adults were studied under normoxia and hypoxia (12% O2).
- Pulmonary artery and radial artery pressures were monitored.
- Subjects inhaled 40 ppm NO during hypoxia and normoxia.
Main Results:
- Hypoxia increased pulmonary artery pressure and cardiac output.
- Inhaled NO during hypoxia selectively reduced pulmonary artery pressure, reversing hypoxic vasoconstriction.
- NO inhalation did not alter systemic vascular resistance or mean arterial pressure.
Conclusions:
- Inhaled nitric oxide (NO) effectively induces pulmonary vasodilation.
- NO selectively reverses hypoxic pulmonary vasoconstriction in humans without systemic effects.
- NO represents a potential therapeutic agent for pulmonary vascular conditions.